236 related articles for article (PubMed ID: 27531690)
21. Correlation between levels of TNF-alpha and IL-6 and hematological involvement in SLE Egyptian patients with lupus nephritis.
Sabry A; Elbasyouni SR; Sheashaa HA; Alhusseini AA; Mahmoud K; George SK; Kaleek EA; abo-Zena H; Kalil AM; Mohsen T; Rahim MA; El-samanody AZ
Int Urol Nephrol; 2006; 38(3-4):731-7. PubMed ID: 17260180
[TBL] [Abstract][Full Text] [Related]
22. Low levels of interleukin-1 receptor antagonist coincide with kidney involvement in systemic lupus erythematosus.
Sturfelt G; Roux-Lombard P; Wollheim FA; Dayer JM
Br J Rheumatol; 1997 Dec; 36(12):1283-9. PubMed ID: 9448589
[TBL] [Abstract][Full Text] [Related]
23. Serum Interleukin-26 Is a New Biomarker for Disease Activity Assessment in Systemic Lupus Erythematosus.
Brilland B; Bach-Bunner M; Gomes CN; Larochette V; Foucher E; Plaisance M; Saulnier P; Costedoat-Chalumeau N; Ghillani P; Belizna C; Delneste Y; Augusto JF; Jeannin P
Front Immunol; 2021; 12():663192. PubMed ID: 34054830
[TBL] [Abstract][Full Text] [Related]
24. Serum biomarkers of inflammation and muscle strength among women with systemic lupus erythematosus.
Andrews JS; Trupin L; Hough CL; Daikh DI; Yelin EH; Katz PP
Cytokine; 2017 Feb; 90():109-112. PubMed ID: 27863333
[TBL] [Abstract][Full Text] [Related]
25. Elevated interleukin-18 levels correlated with disease activity in systemic lupus erythematosus.
Park MC; Park YB; Lee SK
Clin Rheumatol; 2004 Jun; 23(3):225-9. PubMed ID: 15168150
[TBL] [Abstract][Full Text] [Related]
26. Association between serum total antioxidant status and flow-mediated dilation in patients with systemic lupus erythematosus: an observational study.
Sincer İ; Kurtoğlu E; Yılmaz Çoşkun F; Aktürk S; Vuruşkan E; Düzen İV; Saraçoğlu E; Aktürk E; Hidayet Ş
Anatol J Cardiol; 2015 Nov; 15(11):913-8. PubMed ID: 25868041
[TBL] [Abstract][Full Text] [Related]
27. Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus.
Rudloff I; Godsell J; Nold-Petry CA; Harris J; Hoi A; Morand EF; Nold MF
Arthritis Rheumatol; 2015 Dec; 67(12):3219-25. PubMed ID: 26314375
[TBL] [Abstract][Full Text] [Related]
28. IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity.
Ye L; Ji L; Wen Z; Zhou Y; Hu D; Li Y; Yu T; Chen B; Zhang J; Ding L; Du J; Huang Z
J Transl Med; 2014 Mar; 12():69. PubMed ID: 24629023
[TBL] [Abstract][Full Text] [Related]
29. Selected acute phase proteins and interleukin-6 in systemic lupus erythematosus patients treated with low doses of quinagolide.
Hrycek A; Pochopień-Kenig G; Scieszka J
Autoimmunity; 2007 May; 40(3):217-22. PubMed ID: 17453721
[TBL] [Abstract][Full Text] [Related]
30. MIF promotes a differential Th1/Th2/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-α in PBMC from active SLE patients.
De la Cruz-Mosso U; García-Iglesias T; Bucala R; Estrada-García I; González-López L; Cerpa-Cruz S; Parra-Rojas I; Gámez-Nava JI; Pérez-Guerrero EE; Muñoz-Valle JF
Cell Immunol; 2018 Feb; 324():42-49. PubMed ID: 29397904
[TBL] [Abstract][Full Text] [Related]
31. Role of T helper 17 cells in the pathogenesis of systemic lupus erythematosus.
Abou Ghanima AT; Elolemy GG; Ganeb SS; Abo Elazem AA; Abdelgawad ER
Egypt J Immunol; 2012; 19(2):25-33. PubMed ID: 23885404
[TBL] [Abstract][Full Text] [Related]
32. Effect of proinflammatory cytokines (IL-6, TNF-α, and IL-1β) on clinical manifestations in Indian SLE patients.
Umare V; Pradhan V; Nadkar M; Rajadhyaksha A; Patwardhan M; Ghosh KK; Nadkarni AH
Mediators Inflamm; 2014; 2014():385297. PubMed ID: 25548434
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins.
Lacki JK; Samborski W; Mackiewicz SH
Clin Rheumatol; 1997 May; 16(3):275-8. PubMed ID: 9184265
[TBL] [Abstract][Full Text] [Related]
34. The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus.
Thanadetsuntorn C; Ngamjanyaporn P; Setthaudom C; Hodge K; Saengpiya N; Pisitkun P
Sci Rep; 2018 Feb; 8(1):2620. PubMed ID: 29422675
[TBL] [Abstract][Full Text] [Related]
35. Collagen triple helix repeat containing-1: a novel biomarker associated with disease activity in Systemic lupus erythematosus.
Wu Q; Yang Q; Sun H
Lupus; 2018 Nov; 27(13):2076-2085. PubMed ID: 30336754
[TBL] [Abstract][Full Text] [Related]
36. Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus.
Mende R; Vincent FB; Kandane-Rathnayake R; Koelmeyer R; Lin E; Chang J; Hoi AY; Morand EF; Harris J; Lang T
Front Immunol; 2018; 9():1250. PubMed ID: 29930551
[TBL] [Abstract][Full Text] [Related]
37. C-reactive protein +1444CT (rs1130864) genetic polymorphism is associated with the susceptibility to systemic lupus erythematosus and C-reactive protein levels.
Delongui F; Lozovoy MAB; Iriyoda TMV; Costa NT; Stadtlober NP; Alfieri DF; Flauzino T; Dichi I; Simão ANC; Reiche EMV
Clin Rheumatol; 2017 Aug; 36(8):1779-1788. PubMed ID: 28567557
[TBL] [Abstract][Full Text] [Related]
38. Elevation of serum CXCL13 in SLE as well as in sepsis.
Schiffer L; Kielstein JT; Haubitz M; Lührs H; Witte T; Haller H; Kümpers P; Schiffer M
Lupus; 2011 Apr; 20(5):507-11. PubMed ID: 21078761
[TBL] [Abstract][Full Text] [Related]
39. Negative correlation between fetuin-A and indices of vascular disease in systemic lupus erythematosus patients with and without lupus nephritis.
Abdel-Wahab AF; Fathy O; Al-Harizy R
Arab J Nephrol Transplant; 2013 Jan; 6(1):11-20. PubMed ID: 23282228
[TBL] [Abstract][Full Text] [Related]
40. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
